Abiopharma

Revvity - Revvity Board Declares Quarterly Dividend

Notification from CorMedix Inc.

Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025

Teladoc - Teladoc Health Announces Chief Financial Officer Transition

New Form 424B5 - Spectral AI, Inc. Filed: 2025-10-23 AccNo: 0001213900-25-101648 Size: 366 KB

New Form 10-Q - Medpace Holdings, Inc. Filed: 2025-10-23 AccNo: 0001668397-25-000110 Size: 5 MB

CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure

Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast

Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025

Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025

Insmed Ranks No. 1 on Sciences 2025 Top Biopharma Employers List

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation

Treace to Report Third Quarter 2025 Financial Results on November 6, 2025

Teladoc Health Announces Chief Financial Officer Transition

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025